Diabetes Medicines

FDA Has Dispatched Warning Letters to 15 Firms
Jul 26, 2013
The US Food and Drug Administration (FDA) has dispatched warning letters to 15 firms, including foreign and domestic to desist from selling their illegally marketed diabetes products. The latest move will help the regulator to curb the ...

Tags: Diabetes'Medicines, active pharma
Eli Lilly and Company Has Reassumed The Worldwide Development and Commercialization Rights
Jan 9, 2013
Eli Lilly and Company has reassumed the worldwide development and commercialization rights for novel basal insulin analog giving a scope to diabetes alliance signed with Boehringer concerning LY2605541. Lilly also considers initiating ...

Tags: Eli Lilly, commercialization rights, Boehringer, company news
Eli Lilly and Company Has Officially Disclosed The LCRDC in Shanghai, China
Jun 1, 2012
Eli Lilly and Company has officially opened the Lilly China Research and Development Center (LCRDC), a diabetes-focused research and development center in Shanghai, China. The focus of LCRDC is on the discovery of new diabetes medicines ...

Tags: Eli Lilly and Company, China Research and Development Center, diabetes